A Single and Multiple Ascending Dose Study of BMS-986318 in Healthy Participants

Withdrawn before enrolling · Phase 1 · Has a placebo group

Conditions studied: Healthy Participants

In brief

A study to evaluate single and multiple ascending doses of experimental medicine BMS-986318 in healthy participants.

Key facts

Study ID: NCT04082741
Run by: Bristol-Myers Squibb
People needed: 0
Starts: 2019-07-18
Expected to finish: 2019-09-12
Last updated by the study team: 2020-01-27

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

Healthy Participants as determined by no clinically significant deviations from normal in medical history, physical examination, ECG and clinical laboratory results as determined by the investigator
Male participants who are sexually active with Women of Child Bearing Potential (WOCBP) must agree to follow instructions for methods of contraception for duration of treatment plus 92 days.
Female participants must have documented proof that they are not of childbearing potential and a negative pregnancy test at screening and within 24 hours before the first dose of study treatment.

You may not qualify if…

Use of any prescription drugs within 4 weeks or use of over-the-counter (OTC) medications or herbal preparations within 2 weeks prior to study treatment administration (except acid controllers, which are not allowed within 4 weeks prior to study treatment administration
Women of Child Bearing Potential (WOCBP) or women who are breastfeeding.
Any major surgery within 12 weeks of study administration Or any history of GI surgeries as listed.(eg, gastric bypass, gastric banding, Roux-en-Y) or gastric- emptying issues that could impact upon the absorption of nutrients.

Where it is running

PRA Health Sciences - Lenexa — Lenexa, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.